Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Down 52.3% in July

Takara Bio Inc. (OTCMKTS:TKBIF) was the recipient of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totalling 43,200 shares, a decrease of 52.3% from the June 30th total of 90,600 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Takara Bio Stock Performance

Shares of OTCMKTS TKBIF opened at $23.20 on Friday. The business’s 50 day moving average price is $23.20 and its 200 day moving average price is $23.20. Takara Bio has a 52 week low of $23.20 and a 52 week high of $23.20.

Takara Bio Company Profile

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.